Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma

Completed · Phase 2

Conditions studied: Glioblastoma, Gliomas

In brief

Patients have a newly diagnosed brain tumor called a malignant glioma and participate in the study to see if it is possible to increase the benefit of temozolomide when given after radiation. A recent study showed that patients with newly diagnosed glioblastoma lived longer when treated with both temozolomide and radiotherapy followed by 6 months of temozolomide than patients treated with radiotherapy alone. Patients will receive standard low dose temozolomide during radiation. After radiation, they will be randomized to receive either more intense temozolomide or continuous low dose temozolomide.

Key facts

Study ID

NCT00200161

Run by

Memorial Sloan Kettering Cancer Center

People needed

127

Starts

2005-08-09

Expected to finish

2017-05-04

Last updated by the study team

2018-03-07

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pathologic evidence of a malignant glioma.
• Tissue block or unstained slides must be available for MGMT analysis.
• Age 18-70
• KPS > 50
• Granulocyte count >1.5 X 109/L
• Platelet count >99 X 109/L
• SGOT < 2.5X upper limit of normal (ULN).
• Serum creatinine < 2X ULN.
• Bilirubin < 2X ULN.
• All patients must sign written informed consent.

You may not qualify if…

• Any prior chemotherapy, radiotherapy and biologic therapy for glioma.
• Any prior experimental therapy for glioma.
• Other concurrent active malignancy (with the exception of cervical carcinoma in situ or basal cell ca of the skin).
• Serious medical or psychiatric illness that would in the opinion of the investigator would interfere with the prescribed treatment.
• Pregnant or breast feeding women.
• Refusal to use effective contraception.

Where it is running

• Memorial Sloan-Kettering at Basking Ridge — Basking Ridge, New Jersey, United States
• Memorial Sloan-Kettering Cancer Center at Commack — Commack, New York, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.